Malignant melanoma – Diagnostics – Overview of Information and Clinical Research

Diagnosing melanoma early can make the difference between a simple procedure and a life-threatening condition. Understanding who needs screening, what tests doctors use, and how diagnosis shapes treatment decisions empowers patients to take control of their health journey and catch this serious skin cancer when it’s most treatable.

Introduction: Who Should Seek Melanoma Diagnostics

Anyone who notices unusual changes in their skin should consider seeking diagnostic evaluation for melanoma. This is especially important because early detection dramatically improves outcomes, with melanomas caught in the earliest stages having a 99% cure rate according to available data^[2]. Knowing when to seek medical attention can truly save your life.

You should schedule a diagnostic appointment if you observe any new spots on your skin or changes to existing moles. The changes might include alterations in size, shape, color, or texture. Sometimes melanoma appears as a sore that doesn’t heal, an unusual bump, or a scaly patch. Even if you’re not sure whether something is concerning, it’s always better to have a healthcare professional examine it^[1].

People with certain characteristics face higher risks and should be particularly vigilant about seeking diagnostics. If you have fair skin, blonde or red hair, and blue eyes, your risk increases. Those with a large number of moles, a personal history of melanoma, or a family history of skin cancer or melanoma should also prioritize regular skin examinations. Additionally, if you’ve experienced significant sun exposure throughout your lifetime, especially sunburns during childhood, you belong to a higher-risk group^[2]^[6].

Regular self-examination of your skin is an important first step in early detection. You are most likely to be the first person to spot melanoma on your body. By routinely checking your skin and any moles, you can identify changes early and bring them to your doctor’s attention. If you’ve already been diagnosed with melanoma once, you have a higher risk of developing another one, making ongoing monitoring even more critical^[2]^[8].

⚠️ Important

Don’t wait for symptoms to become severe before seeking medical attention. Melanoma grows quickly and can spread to other organs if left untreated. A treatment delay can sometimes mean the difference between life and death. If you notice any skin changes or have concerns about a mole, see your healthcare provider as soon as possible.

Diagnostic Methods for Identifying Melanoma

Visual Skin Examination

The diagnostic process typically begins with a thorough visual examination of your skin. Your healthcare professional will ask questions about your health history, including any family history of melanoma or skin cancer, your lifetime sun exposure, and any changes you’ve noticed in your skin. They will then examine your skin carefully, looking for signs that could indicate melanoma^[11].

During the physical examination, doctors use a specific set of criteria to evaluate suspicious spots. The most commonly used memory tool is called the ABCDE rule, which helps identify warning signs. The “A” stands for asymmetry, meaning one half of the spot doesn’t match the other half. “B” refers to border irregularity, where the edges are not smooth or even. “C” represents color variations, with mottled and uneven shades of brown, black, gray, red, or white appearing in the same spot. “D” indicates diameter, with concerning spots typically being larger than the tip of a pencil eraser, which is about 6 millimeters. Finally, “E” stands for evolving, meaning the spot is new or has been changing in size, shape, or color over time^[2]^[6].

Another diagnostic approach is the “ugly duckling” sign. If one of your moles looks noticeably different from all your other moles, it stands out like an ugly duckling among beautiful swans. This different-looking mole should be examined by a specialist called a dermatologist, who is a doctor specializing in skin conditions^[2].

It’s important to understand that not all melanomas follow the ABCDE rule. Some may appear as sores that won’t heal, unusual bumps, or rashes. This is why any persistent skin changes should be brought to your doctor’s attention, even if they don’t match the classic warning signs^[2].

Biopsy Procedures

When a suspicious skin lesion is identified during visual examination, a biopsy must be performed to confirm whether it is melanoma. A biopsy is a procedure where a sample of tissue is removed from your body and examined under a microscope in a laboratory. This is the only way to definitively diagnose melanoma^[3]^[11].

The preferred biopsy method is called an excisional biopsy. During this procedure, a scalpel is used to cut out the entire suspicious growth along with some surrounding healthy skin. This approach ensures that the entire lesion can be examined. Typically, stitches are needed to close the wound after the tissue is removed. An excisional biopsy is considered the gold standard because it provides the most complete information about the suspicious area^[3]^[11].

Another type of biopsy is the punch biopsy. This technique uses a round-tipped cutting tool that is pressed into the skin to remove deeper layers of tissue for testing. Depending on the size of the sample taken, stitches may or may not be needed to close the wound. For thinner lesions, doctors sometimes perform what’s called a saucerized removal, which removes the tissue in a way that minimizes scarring^[11]^[6].

If the suspicious area is large or has multiple colors, the doctor may need to sample each different colored section. This ensures that if melanoma is present, it won’t be missed. For suspected cases of a specific type called lentigo maligna on the face, careful sampling of different areas may be necessary^[6].

Determining Melanoma Characteristics

After a biopsy confirms that melanoma is present, additional examination of the tissue helps doctors understand important characteristics of the cancer. By looking at the melanoma under a microscope, specialists can determine the thickness of the tumor, which is one of the most critical pieces of information. Generally, the thicker the melanoma, the more serious the disease. The thickness directly affects your treatment plan and prognosis^[11].

Laboratory analysis also reveals whether the melanoma shows ulceration, which means the surface layer of skin covering the tumor has broken down. The presence of ulceration indicates a more aggressive melanoma and influences treatment decisions. Other features examined include how fast the melanoma cells are dividing, which is measured by something called the mitotic index, and whether there is lymphovascular invasion, meaning cancer cells have entered blood vessels or lymph vessels^[15].

Lymph Node Examination

If you’ve been diagnosed with melanoma, your healthcare team will examine all your lymph node groups during the physical examination. Lymph nodes are small, bean-shaped structures that are part of your immune system and help fight infections. Melanoma can spread to nearby lymph nodes, so checking them is an important part of diagnosis^[6].

A procedure called sentinel lymph node biopsy may be recommended depending on your melanoma’s characteristics. This test identifies the first lymph node that fluid from the tumor area drains into. If melanoma has spread beyond the original site, it will most likely appear first in this sentinel node. The procedure helps doctors determine whether the cancer has begun to spread and guides decisions about further treatment^[3]^[6]^[15].

Imaging Studies

For melanomas that have grown deeper into the skin or when there are signs that the cancer may have spread, imaging studies may be ordered. These tests create pictures of the inside of your body to look for melanoma in other locations. A chest X-ray is a simple imaging test that can check your lungs for any signs of spread^[6].

More advanced imaging techniques include computed tomography or CT scans, which use X-rays and computers to create detailed cross-sectional images of your body. CT scans may be used to examine the chest, abdomen, or pelvis. Magnetic resonance imaging, or MRI, uses magnets and radio waves instead of X-rays to create detailed images, and is particularly useful for examining the brain^[6].

Positron emission tomography, often combined with CT scanning (PET-CT), may be considered the best imaging study for identifying sites where melanoma has spread throughout the body. This test uses a small amount of radioactive material to highlight areas where cancer cells are active. Ultrasonography, which uses sound waves to create images, may be the best option for diagnosing lymph node involvement^[6].

Blood Tests

While no blood test can diagnose melanoma, certain blood tests may be helpful in some cases. A test that measures lactate dehydrogenase or LDH in your blood may be ordered. LDH is an enzyme that can be elevated when melanoma has spread to other organs. A complete chemistry panel, which examines various substances in your blood, may also be performed to assess your overall health and organ function^[6].

Diagnostics for Clinical Trial Qualification

When patients are being considered for enrollment in clinical trials testing new melanoma treatments, additional diagnostic tests are often required beyond those used for standard diagnosis. Clinical trials are carefully designed research studies that test new approaches to treating disease, and they have specific criteria that participants must meet^[10].

A complete excisional biopsy is typically required to confirm the melanoma diagnosis before enrollment in a clinical trial. The biopsy tissue may undergo additional specialized testing not routinely done for all melanoma patients. For example, samples may be tested for specific genetic changes or mutations, which are alterations in the DNA of cancer cells. One important genetic test looks for something called the BRAF V600 mutation, which is present in some melanomas and affects which treatments might work best^[15].

Gene profiling assays, which are comprehensive analyses of multiple genes within the melanoma cells, may be performed. These tests help researchers understand the molecular characteristics of the tumor and determine whether a patient’s melanoma has the features that the experimental treatment is designed to target^[6].

Imaging studies are commonly required as part of clinical trial screening. These baseline scans document the extent of disease before treatment begins and provide a comparison point to measure whether the experimental treatment is working. Depending on the trial, patients may need chest X-rays, CT scans, MRI scans, PET scans, or a combination of these imaging techniques^[6].

If the melanoma has involved lymph nodes, a complete lymph node dissection, which is surgical removal of lymph nodes in a particular area, may be performed both for treatment and to provide detailed information about disease extent. The results help determine whether a patient meets the trial’s requirements regarding disease stage^[15].

Blood tests beyond basic chemistry panels may be required for clinical trial enrollment. These can include detailed immune system assessments, measurements of specific proteins or markers in the blood, and tests to ensure that major organs are functioning well enough for the patient to safely receive experimental treatments. Each clinical trial has its own specific list of required diagnostic tests, which are designed to ensure patient safety and that the trial can accurately measure the treatment’s effects^[6].

Understanding why these additional diagnostic tests are necessary can help patients feel more comfortable with the clinical trial process. The tests ensure that the treatment being studied is appropriate for their specific type of melanoma and that participating in the trial is safe for them. They also help researchers gather the detailed information needed to understand whether new treatments are effective.

Prognosis and Survival Rate

Prognosis

The prognosis for melanoma patients depends heavily on when the cancer is detected and several characteristics of the tumor. Early detection is the single most important factor affecting outcomes. Treatment success is directly related to the depth of the cancerous growth, meaning how far the melanoma has penetrated into the layers of skin. The thicker the melanoma, the more serious the disease becomes and the greater the chance it may spread to other parts of the body.

Several factors influence how melanoma will progress and what a patient’s chances of improvement or recovery might be. The presence of ulceration, where the surface layer of skin over the tumor has broken down, indicates a more aggressive melanoma with a less favorable prognosis. Whether cancer cells have spread to lymph nodes is another critical factor. Additionally, certain characteristics visible under the microscope, such as a high mitotic index (meaning cancer cells are dividing rapidly) or lymphovascular invasion (cancer cells in blood or lymph vessels), can indicate a higher risk of the cancer spreading.

An individual’s risk of the melanoma spreading to distant parts of the body, a process called metastasis, is directly related to the depth of invasion and ulceration of the primary tumor. Melanoma can spread locally within the skin, regionally to nearby lymph nodes, or distantly to organs such as the liver, lungs, bones, and brain. When melanoma spreads to distant organs, treatment becomes more difficult and outcomes are generally less favorable.

Survival Rate

Survival statistics for melanoma vary dramatically depending on the stage at which the cancer is diagnosed. For patients with stage 0 melanoma, also called melanoma in situ where cancer cells are only in the outermost layer of skin, the five-year relative survival rate is approximately 97%. Melanomas caught in the earliest stages have a 99% cure rate when treated promptly.

In contrast, the five-year relative survival rate drops to about 30% for patients with stage IV disease, where melanoma has spread to distant organs. This dramatic difference underscores why early detection through regular skin examinations and prompt medical attention for suspicious skin changes is so critically important. When melanoma is detected and treated early, the estimated five-year survival rate is 99%. Before age 50, melanoma rates are higher in women than in men, but after age 50, rates become much higher in men.

It’s important to understand that survival rates are statistics based on large groups of people and cannot predict exactly what will happen to any individual patient. Many factors influence an individual’s prognosis, and treatment options have improved significantly in recent years, particularly for advanced melanoma. Survival rates also represent data from patients diagnosed and treated several years ago, and newer treatments may offer better outcomes than these statistics reflect.